RECRUITINGOBSERVATIONAL
Essen Amyloidosis Registry
About This Trial
The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to improve the understanding of disease progression, diagnostic pathways, and treatment outcomes. The registry is hosted at the University Hospital Essen and follows patients longitudinally. Inclusion is open to all patients with suspected or confirmed amyloidosis who provide informed consent.
Who May Be Eligible (Plain English)
Who May Qualify:
- Suspected or confirmed amyloidosis (any)
- Written willing to sign a consent form to participate in the study
- Age 18 years and above
Who Should NOT Join This Trial:
- Age \< 18 years
- Lack of written willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Suspected or confirmed amyloidosis (any)
* Written informed consent to participate in the study
* Age 18 years and above
Exclusion Criteria:
* Age \< 18 years
* Lack of written informed consent
Locations (1)
University Hospital Essen
Essen, North Rhine-Westphalia, Germany